Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Leo Pharma Oy
OY
Active
Y-tunnus 0807589-1
Karhumäentie 3, 01530
Vantaa
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1990 · 35 years old
4 employees
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Leo Pharma Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
3M
7M
10M
14M
11M
2020
12M
2021
10M
2022
11M
2023
11M
2024
EBITDA
EUR millions
1M
1M
1M
0M
0M
1M
2020
0M
-100%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Income statement
EUR thousands
Item
2020
2021
2022
2023
2024
Revenue
10 657
11 543
9 537
10 840
10 943
Staff expenses
−931
−986
−763
−544
−565
EBITDA
682
−9
299
334
342
Depreciation & amort.
−4
−2
−0
−0
−0
EBIT
678
−11
299
334
342
Net financials
−8
−45
−83
−56
−0
Profit before tax
670
−56
216
277
342
Tax
143
−0
22
54
100
Net profit
527
−56
194
223
243
Balance sheet
EUR thousands
Item
2020
2021
2022
2023
2024
Total assets
4 483
9 228
7 335
4 857
4 057
Equity
1 303
1 247
1 440
1 664
1 906
Long-term debt
165
45
37
0
0
Short-term debt
3 015
7 936
5 858
3 193
30 225
Total debt
3 180
7 981
5 895
3 193
2 151
Financial ratios
5-year trend
EBITDA margin
3.1%
This company
15.8%
Market median
-80% vs market
2020
2024
Equity ratio
47.0%
This company
38.2%
Market median
+23% vs market
2020
2024
Return on equity
12.7%
This company
18.4%
Market median
+31% vs market
2020
2024
Net profit margin
2.2%
This company
8.1%
Market median
-73% vs market
2020
2024
Asset turnover
2.70×
This company
1.12×
Market median
+141% vs market
2020
2024
Debt / equity
1.13×
This company
0.62×
Market median
-82% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
View
PDF
More on Leo Pharma Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
